![](/img/cover-not-exists.png)
691 - The LHRH analogue triptoreline (TAP) with or without the aromatase inhibitor formestane (4-OHA) in premenopausal advanced breast cancer: A study by the I.T.M.O. group
L. Celio, A. Martinetti, L. Ferrari, R. Buzzoni, E. Bombardieri, N. Zilembo, L. Maiorino, E. BajettaVolume:
33
Year:
1997
Language:
english
DOI:
10.1016/s0959-8049(97)85286-0
File:
PDF, 257 KB
english, 1997